Published Results Show MSB Cells Effective In RA Model
Filed with ASX · · 2 pages · English
In the deck
Story so far
Earlier from Mesoblast
- Mesoblast Director Recognized For Cardiovascular Leadership
- Mesoblast And Mallinckrodt Enter Into Agreement
- MD Anderson and NIH Fund Trial Using Mesoblast Technologies
- First Quarter Results On Form 6K
- Successful Interim Futility Analysis In P3 Trial for GVHD
Later from Mesoblast
- Positive Nine Month RA Results For Mesoblast Cell Therapy
- FDA Grants Mesoblast Fast Track Designation For GVHD
- Durable Three Year Outcomes in Disc Disease
- Mesoblast Raises US$40 Million
- Process Initiated For CHF P3 Interim Analysis
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast